NCT04504942 2026-01-23Basket Study of Leronlimab (PRO 140) in Patients With CCR5+ Locally Advanced or Metastatic Solid TumorsCytoDyn, Inc.Phase 2 Completed16 enrolled 16 charts
NCT04020185 2024-12-11Safety and Efficacy Study of IMSA101 in Refractory MalignanciesImmuneSensor Therapeutics Inc.Phase 1/2 Completed40 enrolled 16 charts